External link, please review our disclaimer.

HIV or AIDS

HIV/AIDS

Brief Description

Drug abuse and addiction have always been inextricably linked to HIV/AIDS. For many years, people often believed that this connection was due only to injection drug use and needle sharing. However, this way of thinking greatly underestimates the impact that drug use and abuse can have on the spread of HIV/AIDS through the risky behaviors it engenders. Drug and alcohol intoxication affects judgment and can lead to risky sexual behavior that puts participants at risk of contracting or transmitting HIV and other sexually transmitted diseases.

Tags:

HIV or AIDS

NIDA supports development of combined anti-heroin and HIV vaccine

Featured on Latest Science:

Not featured

Dr. Gary R. Matyas has been selected the 2012 recipient of the NIDA Avant-Garde Award for Medications Development. Matyas proposes to develop an effective, safe and easily manufactured combination anti-heroin/HIV vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine. Matyas will receive $1,000,000 per year for five years to support his research. He works at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, M.d.

Tags:

HIV or AIDS

NIDA Announces 2012 Avant-Garde Award for Medications Development

Featured on Latest Science:

Not featured

NIDA’s Dr. Nora D. Volkow will announce the winner of the 2012 Avant-Garde Award for Medications Development during the XIX International AIDS Conference in Washington, DC. This research competition, now in its third year, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of drug abuse. This year’s winner will receive $1,000,000 per year for five years in research support.

Tags:

HIV or AIDS

The Present and Promise of mHealth

NIDA researchers have developed a computer program that motivates and encourages treatment-seeking when an individual is in a primary care physician’s waiting room. Users of the program, called Video Doctor, enter information on a portable device and receive feedback about health risks related to their drug abuse, along with advice, immediately prior to seeing their physician.

Tags:

Providers Defer HIV Treatment for Injection Drug Users (IDUs)

Providers defer HIV treatment for injection drug users.

Healthcare providers often put off antiretroviral therapy for HIV patients who inject drugs--even those with high levels of infection. A new study shows the surprising scope of this treatment disparity in North America.

Tags:

Women and Sex/Gender Differences Research Program

NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Tags:

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

Tags:

Blending conference translates substance abuse research into practice

Featured on Latest Science:

Not featured

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia. The program is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, in collaboration with the American Society of Addiction Medicine Annual Medical-Scientific Conference as part of an ongoing initiative to accelerate research findings into practice.

Tags:

HIV/AIDS researcher David Ho wins NIDA's 2011 Avant-Garde Award

Dr. David Ho

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today that Dr. David Ho of the Aaron Diamond AIDS Research Center in New York, NY, has been selected as the 2011 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research. Ho's proposal aims to develop a novel HIV therapy that could be administered monthly; as opposed to the existing daily treatment for HIV.

Tags:

Latest Information on MDMA/Ecstasy, Steroids, and HIV/AIDS Is Available on NIDA's Web Site

Announces updates to research reports on MDMA/ecstasy and steroids and a new report on HIV/AIDS that provide the latest available information on drugs and drug-related topics.

Tags: